We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the fees applicable under the hemp licensing regime.
First published during the 2022 to 2024 Sunak Conservative government
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Charges for NHS prescriptions, wigs and fabric supports will increase on 1 May 2024.
Ventilators, oxygen concentrators, pumps and monitors among kit donated to Ukraine.
Consultant unions have voted overwhelmingly in favour of the government's offer, with BMA and HCSA voting yes by around 83%.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
UKHSA has published the latest data on scarlet fever cases in England. Scarlet fever is circulating, as expected for this time of year.
The expansion of testing on arrest across England and Wales has seen nearly 100,000 drug tests on suspects whose behaviour was believed to have been driven by their drug abuse.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
The move will streamline processes within dental and pharmacy settings and improve patient experiences.
Report shows vaccine coverage for children in the UK at 12 months, 24 months and 5 years
Thousands of counterfeit or unbranded copies of LifeVac anti-choking devices are being sold across the UK. The public is reminded to check their product carefully against the images in MHRA guidance to identify whether it is…
Those in frontline roles such as community nurses and physiotherapists will benefit, with organisations receiving funding for the payments in the coming months.
Consultation launched on proposals to expand scheme to 1.6 million more people to help tackle tooth decay.
A new government campaign will be launched to support parents as research highlights some are unaware their baby's mental health impacts their early development.
Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.
UKHSA is reminding travellers of steps they can take to reduce the risk of infections .
Draws attention to 2 statutory instruments which amend the Misuse of Drugs Act 1971 and associated regulations to control and schedule 20 new drugs.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).